HOME >> MEDICINE >> NEWS
Large tularemia vaccine contracts among new NIAID biodefense awards

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced that it has recently made several dozen awards to further strengthen the nation's biodefense and emerging disease research capabilities. The new awards include grants totaling approximately $87 million for the construction of four biosafety level-3 (BSL-3) laboratories as well as two five-year contracts totaling approximately $60 million to support the development of a vaccine against tularemia, a potential agent of bioterror.

"Devising medical countermeasures against biological threats, whether they arise naturally or are the result of deliberate human action, is a top priority for NIAID," says NIAID Director Anthony S. Fauci, M.D. "These new awards support research needed to better understand and defend against disease-causing microbes and provide funds to construct facilities where such research can be performed safely."

Regional Biocontainment Laboratories

The four new labs will join nine other NIAID-funded BSL-3 labs in the Institute's Regional Biocontainment Laboratory (RBL) program. In 2002, a panel of experts convened to provide guidance to NIAID on its biodefense agenda cited insufficient BSL-3 and BSL-4 space as a major barrier to research progress. As part of its response, NIAID established the RBL program to fund the design, construction and commissioning of state-of-the-art BSL-3 labs at sites spanning the country. The institutions receiving the new awards and the principal investigators are as follows:

  • Charles Bailey, Ph.D., George Mason University, Manassas, VA
  • Sawkat Anwer, D.M.V.H., Ph.D., Tufts University, North Grafton, MA
  • Nancy Martin, Ph.D., University of Louisville, KY
  • James Gaines, Ph.D., University of Hawaii at Manoa

More information about NIAID's biocontainment facility construction program and a map of the previously awarded sites is at <
'"/>

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
3-Oct-2005


Page: 1 2 3

Related medicine news :

1. Largest ever grant for University of Copenhagenhagen
2. Large subset of learning disabled children can be quickly identified by new diagnostic device
3. Large collaborative effort provides first publicly available genetic data for Parkinsons research
4. Largest review of Loeys-Dietz Syndrome to date
5. Large-scale cross-platform study of research microarrays uncovers high concordance across platforms
6. Large NCI grant will test the effect of Tibetan yoga on women with breast cancer
7. Large prospective study examines colon cancer risk in women
8. Large study shows low-fat diet has little effect on reducing risk of breast cancer
9. Largest study of in-hospital cardiac arrest suggests how to improve outcomes for children and adults
10. Large-scale study proves volunteer operated defibrillators are life-savers
11. Largest survey on depression suggests higher prevalence in U.S., reports Mailman school

Post Your Comments:
(Date:3/29/2015)... At the 2015 International Health Racquet ... introduced the new Fonda wall mounted heater and a ... owners and facilities managers with saunas smaller than 425 ... of the Fonda heater. With an attractive seamless ... immediate upgrade for a sauna, especially when mounted in ...
(Date:3/29/2015)... 2015 Pro Ace Care Heating & ... now provide qualified HVAC technicians that will visit the ... and related systems throughout Vancouver, North Vancouver, Burnaby, Richmond, ... conditioners, heat pumps require regular maintenance from a professional. ... BC Hydro strongly suggest you have it serviced annually ...
(Date:3/29/2015)... Calif. (PRWEB) March 30, 2015 Over ... menopause-related symptoms tied to undiagnosed autoimmune, thyroid, or hormone ... thyroid disorders, has personally treated hundreds of patients dealing ... are unaware of the treatment options for their ailments. ... offers solutions to women living with fatigue, brain fog, ...
(Date:3/29/2015)... 2015 Elfster.com, the top-rated Secret Santa ... promotional plans to publicize its gift exchange generator technology ... Known as the leader in Secret Santa online gift ... adjacent markets can see the opportunities as well. , ... explained Peter Imburg, CEO of Elster.com. "With Christmas and ...
(Date:3/29/2015)... Orion, Clarkston, Metamora, MI. (PRWEB) March 29, 2015 ... Beaumont Hospital, offers comprehensive menopause treatment. Secondary to ... that area a closer hospital option. They continue ... and McLaren Oakland. , Menopause is a ... The term "menopause" can describe any of the changes ...
Breaking Medicine News(10 mins):Health News:Helo Commercial Introduces Fonda Sauna Heater and Sauna and Steam Continuing Education Program at IHRSA 2Health News:Pro Ace Care Now Provides Qualified HVAC Technicians for Heat Pump Maintenance 2Health News:How to Turn Mid-life into the Good Life 2Health News:Gift Exchange Generator Promotion Achieves Early Success, Announces Elfster 2Health News:Women's Excellence Affiliates with Beaumont Hospital, Treats Menopause 2
(Date:3/29/2015)...  Three-month paliperidone palmitate, an investigational atypical antipsychotic, ... in patients with schizophrenia, according to a new ... the Journal of the American Medical ... of the study served as the basis for ... three-month paliperidone palmitate injection to treat schizophrenia in ...
(Date:3/27/2015)... BioCorRx, Inc. ( BICX ) ... a healthcare solutions organization, which focuses solely on addiction treatment; ... the U.S. alone. The Company created a unique treatment program ... compounded form for outpatient surgical implantation. The Company has exclusive ... New Zealand ) to the specially formulated Naltrexone implant. ...
(Date:3/27/2015)... CHAPEL HILL, N.C. , March 27, 2015 /PRNewswire/ ... function is essential to meeting challenges in clinical development, ... and face tighter regulations, the Medical Affairs function is ... charted by mature markets. According to ... market study participants have a group dedicated to Medical ...
Breaking Medicine Technology:New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 2New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 3New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 4New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 5New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 6New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 7New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 8New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 9New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 10New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 11New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 12Small Cap IR Correction -- BioCorRx Inc. Positions Itself Through Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S. 2Medical Affairs Capabilities Expanding in Emerging Marketplaces 2
Cached News: